Twitxy Saved

Maria C Carrillo PhD

@DrMariaALZ

Chief Science Officer & Medical Affairs Lead
Joined July 2013
305 Following 3.8K Followers 1.3K Posts

Latest posts 5

Maria C Carrillo PhD @DrMariaALZ
Proud to share that Part the Cloud is investing nearly $7 million in 5 promising Alzheimer's therapies to help move them into clinical trials — combination strategies, a repurposed diuretic and our first AI-designed antibody therapy. Learn more: bit.ly/4ruxb02
www.alz.org Alzheimer's Association Part the Cloud Grants $7 Million Funding aims to accelerate visionary Alzheimer's and dementia treatment candidates into clinical trials. To date, Part the Cloud has funded 88 trials across the globe.
2 replies 2 reposts 17 likes 690 views View on X
Maria C Carrillo PhD @DrMariaALZ
4 FDA-cleared blood tests for Alzheimer's diagnosis & 2 cleared within a few days of each other. It's the kind of progress we've been working toward for decades. This is the research community doing what it does best: turning ideas and discovery into real tools for real people.
Alzheimer's Association Verified account @alzassociation Aug 24
Breaking News: Today, the U.S. Food and Drug Administration (FDA) cleared a fourth Alzheimer’s blood test for people experiencing signs or symptoms of cognitive impairment. This is the second blood-based biomarker test to be cleared in the past week.

Read our statement: bit.ly/3SMm6KO.
View quoted post on X
0 replies 11 reposts 18 likes 782 views View on X
Maria C Carrillo PhD @DrMariaALZ
Advances like this matter for people and families seeking answers. See below for our full statement.
Alzheimer's Association Verified account @alzassociation Aug 20
📰 Breaking News: The U.S. Food and Drug Administration (FDA) has cleared the third Alzheimer's blood test for individuals experiencing signs or symptoms of cognitive impairment. This is the first blood test cleared for use in patients as young as 40.

Read our full statement: bit.ly/3TZ8fBg.
View quoted post on X
1 replies 2 reposts 18 likes 1.3K views View on X
Maria C Carrillo PhD @DrMariaALZ
At #AAIC26 last week, we announced PROTECT-Cog to evaluate whether combining lifestyle intervention with a metabolism-targeting drug like a GLP-1 agonist can further reduce dementia risk. That’s a $100 million commitment – in science, progress, and people.
Alzheimer's Association Verified account @alzassociation Jul 13
📰 Today the Association announced the launch of the PROTECT-Cog Study to test U.S. POINTER lifestyle and GLP-1 or similar drug to cut risk of cognitive decline. Learn More: bit.ly/4pekZiJ
View quoted post on X
2 replies 4 reposts 12 likes 948 views View on X
Maria C Carrillo PhD @DrMariaALZ
This LatAm-FINGERS news from #AAIC26 is big. Not just for science, but for the power of global scientific collaboration. Check out The Lancet paper!
thelancet.com/journals/lance…
www.thelancet.com Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults... A culturally adapted multidomain lifestyle intervention was feasible across Latin America and resulted in greater cognitive improvements than a flexible health-advice intervention in older adults at...
Alzheimer's Association Verified account @alzassociation Jul 13
📰 Breaking news from #AAIC26: Lifestyle program improves brain health among older adults at risk for dementia across Latin America — confirming and expanding Alzheimer’s Association-funded U.S. POINTER Trial results. Learn More: bit.ly/4f7dJ3z
View quoted post on X